text:
No. 8: Steelers WR Hines Ward
WHAT IS #NFLAnyEra?
Our #NFLAnyEra panel includes Mike Ditka, Larry Csonka, Joe Namath, Jim Brown and
16 other Pro Football Hall of Famers.
About our HOF panel »
SportsNation: Rank the players
Or, to put a finer point on it -- when Mike Ditka looks at today's player, whom does he want lining up next to him or across from him?
Which of today's players did our group of Hall of Famers deem really old school?
The playing days for our 20-member Hall of Fame panel spanned the '60s (Jim Brown) to the turn of the century (John Randle).
We'll present four players a day, culminating with our top four on Friday, Jan. 27.
Use the #NFLAnyEra Twitter hashtag to get involved in the conversation or just follow along at @ESPN or on our Facebook page.
Honorable mention and No. 20 | 19 | 18 | 17 | 16 | 15 | 14 | 13 | 12 | 11 | 10 | 9 | 8
7 | 6 | 5 | 4 | 3 | 2 | 1 | NFL Blog Network reaction
LYNN SWANN: Is there another receiver in the past 12 years who has a tougher reputation than Hines? If we are talking about being tough, then I don't know how you can't choose him. I'd like to go out of the box, but Hines fits this category too well. There are some very talented receivers in this league, and they'll catch the ball and then get out of bounds. It might not always be the best decision, but whenever he catches the ball he turns and fights for every yard. He takes guys on, he'll block and I mean really block.
When another receiver catches the ball, Hines is running down the field looking to make a play, and his block can be the difference between a 5-yard run and a 50-yard touchdown run. At wide receiver, you just don't see guys looking for contact very often. The mindset of any skill player is to avoid contact, get the ball and not get hit. You know you are going to get hit, but the object is not to get hit. Anyone who gets the ball should be looking to escape, but you don't see Hines going to the ground in most cases.
You just see him lowering his shoulder.
LARRY CSONKA: I like Hines Ward for his size and toughness and flat-ass orneriness. He has the temperament to play anywhere, any time. He makes big catches, big blocks and has the disposition that would allow him to play in any era. He doesn't bother with the trivial stuff. He plays to win and he knows, most of the time, he will.
JAMES LOFTON: I think there are a lot of guys who stick their noses in there and block, but the fact is Hines has been doing it for so long. To do it year after year after year is where you earn your stripes. He has played so long that he's lost a couple of steps, but he's still a tough, physical player. When he was in his heyday, he would do anything out there that they asked him to do. He did some unique things that other receivers wouldn't do.
JOHN RANDLE: The thing about Hines is he would crack you in a second. You had to have your head on a swivel. You'd watch a game just to see who Hines would crack on. He'd try to line up at tight end, and you knew if there was going to be a crack, it was Hines crackin' somebody. And then afterward, he'd have that grin on his face. Because it was on you; he'd say, "Hey, stop me." That was his reputation for me. As a football player, I look at it like the Western days, being an outlaw and you'd go from town to town to defend your reputation. And they knew you were coming. For Hines, there was that smile on his face, and you'd see it on tape, "Hey, I got ya."
Hines Ward has built a reputation as the best blocking wide receiver in football. He came into the NFL thinking he was tough, but he soon realized what it meant to be tough in the league. In his third season, Ward knocked helmets with Chargers safety Rodney Harrison on Dec. 24, 2000, which has left a lasting impression to this day.
I put the best and hardest hit on this guy. I thought I crushed him. He looks back, shakes his head and says, "Yeah, 86, that's what I'm talking about. I like that."
I looked from the huddle, and thought, "Oh no." That will always stick with me for the rest of my life. Just the type of player he was. I brought it. I hit him harder than anybody ever and all he did was move his head side to side. At the time, he didn't even know who I was. That's when I knew the NFL was real. I've always took the mode that, yes, I'm a wide receiver. I like to look at myself as a football player. I remember the one-on-one battles and blocking the strong safeties throughout the league.
As a route-runner and pass-catcher, Ward knows how to get open for his quarterback. But what puts him on this list is his tough mentality. As a blocker, he's ruthless. Old-school football was a street fight, and any great team from the old days would love to have his knockout punch. In the old days, receivers going across the middle of the field expected to be decked or given a forearm shiver. Ward never fears going across the middle. Receivers might be divas. Ward isn't. He's a tough player who just happens to catch the football.
CLAYTON ON HALL OF FAME CHANCES: Receivers have a tough time making it. Just ask Cris Carter, Andre Reed and Tim Brown. Might be tough.
John Clayton, a recipient of the Pro Football Hall of Fame's McCann Award for distinguished reporting, is a senior writer for ESPN.com. Follow Clayton on Twitter @ClaytonESPN
Wow! - That's all I can say! Shaking my head! What an honor it is to be selected for the NFL's Any ERA list.... fb.me/1ldxMfCWZ
— Hines Ward (@mvp86hinesward) January 27, 2012
#NFLAnyEra YAY for @mvp86hinesward :) @jharrison9292 deserved better than 10! Happy that 2 #Steelers left in Top 4! Ben & Troy?
— Megan Eaton (@mleaton) January 26
The one current player that should be in #NFLAnyEra is Hines Ward. He is old school, the best blocking WR and a great possession guy.
— Adam Steinfield (@ASteinfield) January 25
#NFLAnyEra hines ward, a rough receiver who could have made catches even before all the rules changes to make passing easier
— James Elam (@thecondor251) January 24
Honorable mention and No. 20 | 19 | 18 | 17 | 16 | 15 | 14 | 13 | 12 | 11 | 10 | 9 | 8
7 | 6 | 5 | 4 | 3 | 2 | 1 | MORE: Twitter | Facebook | NFL Blog Network
Additional reporting by ESPN The Magazine's Morty Ain, Louise Cornetta, Amy Parlapiano and Alyssa Roenigk.
- No. 20: Colts QB Peyton Manning
- No. 19: Broncos QB Tim Tebow
- No. 18: Lions DT Ndamukong Suh
- No. 17: Colts DE Dwight Freeney
- SportsNation: Rank 'em
- No. 16: Vikings DE Jared Allen
- No. 15: Jets DB Darrelle Revis
- No. 14: Ravens RB Ray Rice
- No. 13: Ravens S Ed Reed
- SportsNation: Rank 'em
- No. 12: Cowboys LB DeMarcus Ware
- No. 11: Patriots QB Tom Brady
- No. 10: Steelers LB James Harrison
- No. 9: Packers QB Aaron Rodgers
- SportsNation: Rank 'em
- No. 8: Steelers WR Hines Ward
- No. 7: 49ers LB Patrick Willis
- No. 6: Vikings RB Adrian Peterson
- No. 5: Bears LB Brian Urlacher
- SportsNation: Rank 'em
- No. 4: Packers CB Charles Woodson
- No. 3: Steelers QB Ben Roethlisberger
- No. 2: Steelers S Troy Polamalu
- No. 1: Ravens LB Ray Lewis
- SportsNation: Rank 'em
- Hensley: HOFers pick Lewis
- #NFLAnyEra: Ray Lewis Q&A
- Panel: HOFers discuss Nos. 4-1
- Panel: HOFers discuss Nos. 8-5
- Panel: HOFers discuss Nos. 12-9
- Panel: HOFers discuss Nos. 16-13
- Panel: HOFers discuss Nos. 20-17
- Panel: NFL Any Era criteria
- Chris Berman: NFL Any Era introduction
- Sando: Willis is toughness personified
- Archer: Ware's timeless recovery
- Page 2: The Anti-Any Era Team
- Hensley: Is Reed the best safety ever?
- Garber: NFL Any Era: Tough Enough?
- ESPN The Magazine: Not-so-tough WRs?
- ESPN The Magazine: Is Suh dirty?
- Gallery: Dream matchups
- Follow: #NFLAnyEra on Twitter
- Like: #NFLAnyEra on Facebook
- Discuss: #NFLAnyEra on NFL Blog Network
- SportsNation: Rank 'em
- McShay: Mariota to Jets in Mock Draft 3.0
- #NFLFrontOffice: Can GB keep Cobb, Bulaga?
- Caplan: Marshall among potential cap cuts
- Sando: How Bucs can bounce back in 2015
- Kiper: Ranking top 40 WRs in draft


text:
on orders of $85 or more
An excerpt from www.HouseOfNames.com archives copyright © 2000 - 2015
Where did the English Ord family come from? What is the English Ord family crest and coat of arms? When did the Ord family first arrive in the United States? Where did the various branches of the family go? What is the Ord family history? Spelling variations of this family name include: Orde, Ord and others. First found in Ord, a village about 2 miles (3 km) south west of Berwick Upon Tweed in Northumberland that dates back to 1196 where it was first listed as Horde. [1] East Ord, Middle Ord and West Ord were all hamlets at one time and all owned by the Ord family until the early fifteenth century. The villages are essentially on the Scottish-English border of today so the family's movement through the ages on both sides is to be expected. This web page shows only a small excerpt of our Ord research. Another 275 words(20 lines of text) covering the years 1086, 1180, 1296, 1781, 1855, 1802, 1832, 1835 and 1852 are included under the topic Early Ord History in all our PDF Extended History products. Another 49 words(4 lines of text) are included under the topic Early Ord Notables in all our PDF Extended History products. Some of the first settlers of this family name were: Ord Settlers in United States in the 17th Century
Ord Settlers in United States in the 18th Century
Ord Settlers in United States in the 19th Century
Ord Settlers in New Zealand in the 19th Century
Other References
The Ord Family Crest was acquired from the Houseofnames.com archives. The Ord Family Crest was drawn according to heraldic standards based on published blazons. We generally include the oldest published family crest once associated with each surname. This page was last modified on 26 March 2014 at 10:20. ©2000-2015 Swyrich Corporation. See Terms of Use for details. houseofnames.com is an internet property owned by Swyrich Corporation. Sign Up
on orders of $85 or more
Company Information Terms of Use Privacy Statement Security Policy TreeCanada Program |

subset: commoncrawl


text:
Faculty Research Home
Faculty Research Spotlight
Federal Regulation & Financial Compliance
Funding Opportunities
Roles and Responsibilities (PDF)
Pre- and Post-Award Forms
Terms, Acronyms & FAQs
Research Compliance
Research Policies
SU FY Report Information USM/SU A-133 Audit Reports FY 2000-2010
Training Resources
University Research Council
Research Home
Student Research
SU is responsible for ensuring that sponsor funds provided by the University to other organizations via subrecipient agreements are spent in accordance with applicable laws and federal regulations.
If a sub-recipient relationship exists, SU is responsible for ensuring adherence with requirements of appropriate standards for good business practices, including internal controls in accordance with OMB Circular A-133 "Audits of States, Local Governments, and Non-Profit Organizations."
SU achieves these assurances through periodic sub-recipient monitoring (on-site visits and the completion of a Management Compliance Questionaire).
The purpose of these procedures is to provide guidance to University staff in monitoring sub-recipients to ensure their compliance with federal laws and regulations.
Recipient or "prime" recipient- is a non-federal entity that receives an award directly from a federal agency to carry out a federal program.
Pass through entity-term for a non -federal entity (SU, state, other) that obtains a federal award and "passes it through" to a sub-recipient.
Sub-recipient-an entity that is responsible for a discreet and substantive portion of a project awarded to a prime recipient or another subrecipient to carry out or administer a program with the responsibility for programmatic decision-making.
Vendor-a dealer, distributor, merchant or other seller providing goods or services that is required for the conduct of a federal program. These goods or services may be for an organization's own use or for the use of beneficiaries of the federal program.
To be a subrecipient an entity must have the following characteristics:
To be a vendor an entity must have the following characteristics:
A. University Research Services:
B. The principal investigator (or his/her designee):


text:
05/03/15 7:17pm
05/03/15 12:43pm
05/03/15 10:01am
05/03/15 9:28am
Arsene Wenger, Thierry Henry and more tell the Invincibles story in a new documentary on Sky Sports.
Luke Campbell and Tommy Coyle are moving closer to their Hull collision.
Paul Smith's world title rematch with Arthur Abraham tops the bill, with David Price and Josh Warrington also in action in Berlin.
David Moyes talks Real Sociedad and his Man Utd exit in a new Sky Sports documentary.
Sky Sports will show 13 live Premier League games in February, including Everton v Liverpool.
Join Quillan Isidore as he provides you with a BMX masterclass from his home track in Peckham.
British Paralympian Sally Brown explains how her love for sprinting first developed when she was at primary school.
Catch live action across 7 sports channels exclusively with Sky Sports - upgrade in minutes
A Sky Sports Day or Week Pass is your ticket to watch every Sky Sports channel live and on loads of devices without a contract. Click here now.
Watch the very latest news brought to you by the UK's leading sports channel, Sky Sports News.
Watch every goal from every game in the Football League on your computer, mobile or tablet...


text:
On Trainer's website, www.sticktowhatyouknow.com, hundreds of people she has never met congregate to generate ideas and comment on her latest endeavors, which she posts religiously. The making of the dead man and the cat man are both detailed in photos and descriptions on the site, and many fans have praised them.
The site has been up for about three years, though Trainer turned it over to a guy from Minnesota while she was retooling after Wilma. Like many collaborative Internet projects, Trainer gets help from virtual strangers. Some, like veterinarian Vanessa Rolfe, make contributions and come to the studio every now and then.
Rolfe, who was present on the egg toss night, plans to become an investor in Chi Chi TV. Others have stumbled in accidentally (or maybe driven by fate). White Bread, who met Trainer while studying at the Fort Lauderdale Art Institute, stopped by to help fix a glitch in a computer that he ended up exacerbating, according to Trainer. He said he didn't understand the point of Chi Chi but agreed to toss eggs anyway. Mike Klockowski, a pilot Trainer knows from her day job, came to take pictures. And then there's Kurtzberg, who works for a bank but likes to take her clothes off. Cruz, of course, is there to help her do it.
Kurtzberg has a starring role in a Chi Chi TV skit that involves her being naked and buried in 600 pounds of sand. A toy helicopter descends on her, blowing the sand first off her right breast, then her left, eventually disrobing her. She also makes an appearance with host Cruz, who holds a red Chi Chi microphone. Again in her bikini, Kurtzberg tackles Cruz in the sand. Kurtzberg says she's not a lesbian, though she believes "all straight girls are two drinks away."
In Cruz's experience, that's certainly been the case. The petite, dark-haired minx has been hitting on women, straight and gay, in bars for more than a decade. She's found that it's fairly easy to talk girls out of their clothes. Her cell phone proves how easy it is, with about 50 pictures of breasts, all taken in bar bathrooms.
"I go straight to the girl I like and I say, 'Hey, are those double D's?' I say, 'They're beautiful. Can I see them?' Or 'Can I have your bra?'" Cruz says she rarely gets rejected. That might be because she's well-put-together and seemingly harmless. She dresses in tight designer jeans, always with a catchy buckle. On a recent evening, she wore a silver profile of the Virgin Mary. She also wears pointy shoes and fancy watches, at the moment sporting a silver Cartier.
Cruz, who runs her own investment business, says she has taken more than 400 women's phone numbers over the past several years, and she keeps them in a wooden box in her apartment. She's attracted to "that really feminine slutty look," and maybe that's why she usually winds up dating strippers, she says. Although she's 38, she looks about 21, which is the age of her current girlfriend a stripper.
Cruz grew up in a Catholic South American family, and her parents don't know she's lesbian. She won't even grant New Times permission to publish the country she's from or her real last name, in fear that somehow it will get back to her parents.
Parental disapproval or not, though, Cruz says she's doing the work of the angels. "I think women are beautiful, and they have to show what they got," she says, her hands outstretched as if to trace a full-bodied figure. "I like women so much. I really enjoy their bodies and their expressions and everything. Just looking at their eyes. It's something I enjoy."
Clearly, if anyone can pull off the next stunt finding two large-breasted women willing to joust, naked, in shopping carts pushed by midgets it's Cruz.


text:
A.T. Utilization Information Center
ClinicalTrials.gov is a web based resource that provides patients, their family members, health care professionals, researchers and the public with access to information on publicly and privately supported clinical studies on a wide range of diseases and conditions. The site is maintained by the National Library of Medicine (NLM) at the National Institutes of Health (NIH). Information on ClinicalTrials.gov is provided and updated by the sponsor or principal investigator of the clinical study. [More Information on ClinicalTrials.gov]
Disability Statistics Center, University of California/San Francisco
The Disability Statistics Center produces and disseminates policy-relevant statistical information on the demographics and status of people with disabilities in U.S. society. The Center's work focuses on how that status is changing over time with regard to employment, access to technology, health care, community-based services, and other aspects of independent living and participation in society. The Center is based at the Institute for Health and Aging at the University of California, San Francisco (UCSF). It receives funding from the National Institute on Disability and Rehabilitation Research (NIDRR) as an RRTC. [More Information on Disability Statistics Center, University of California/San Francisco]
Quality of Life Technology Center
The Quality of Life Technology (QoLT) Center is a National Science Foundation Engineering Research Center (ERC). QoLT was created to significantly improve and sustain the quality of life for all people by integrating information, engineering, and biomedical innovations for the prevention, rehabilitation and compensation of human ailments. The center is developing new approaches to help manage and maintain physical and mental health, and devices and systems that both restore and enhance natural human perception, cognition, and motor skills for people with reduced functional capabilities due to aging or disability. QoLT is a unique partnership between Carnegie Mellon and the University of Pittsburgh that brings together a cross-disciplinary team of technologists, clinicians, industry partners, end users, and other stakeholders to create revolutionary technologies that will improve and sustain the quality of life for all people. [More Information on Quality of Life Technology Center ]
View State Specific Organizations
Conferences Return to top of page
Past Conferences Return to top of page
2014 Rehabilitation Engineering and Assistive Technology Society of North America (RESNA) Annual Conference
June 13, 2014 to June 15, 2014 in Indianapolis, Indiana, United States
The RESNA 2014 Annual Conference will be an interdisciplinary gathering of individuals and companies who share a common interest in rehabilitation engineering, assistive technology and disability issues in general. The conference schedule will include workshops and plenary sessions. Mixed in are dozens of meetings of committees, SIGs (shared interest groups) and PSGs (professional specialty groups). [More Information on 2014 Rehabilitation Engineering and Assistive Technology Society of North America (RESNA) Annual Conference]
2014 Assistive Technology Industry Association (ATIA) Conference and Exhibition
January 29, 2014 to February 1, 2014 in Orlando, Florida, United States
ATIA 2014 Orlando will be one of the foremost learning and networking event for professionals, parents, and students in the field of Assistive Technology (AT). Exhibitors, presenters and attendees will learn the latest cutting edge information, products, services and best practices in AT for service professionals serving children, students and adults with disabilities. Participants can hear first-hand from product leaders and successful practitioners how AT is a transformative power for the services they provide and the individuals with disabilities they serve. Participants also will be able to connect face-to-face with top AT experts while networking with and learning from like-minded peers from around the world. [More Information on 2014 Assistive Technology Industry Association (ATIA) Conference and Exhibition]
2014 CSUN International Technology and Persons with Disabilities Conference
March 17, 2014 to March 22, 2014 in San Diego, California, United States
The 2014 CSUN Conference will provide an inclusive setting for researchers, practitioners, exhibitors, end users, speakers and other participants to share knowledge and best practices in the field of assistive technology. The 29th edition of this conference will be a forum that showcases cutting edge technology and practical solutions that can be utilized to remove the barriers that prevent the full participation of persons with disabilities in educational, workplace and social settings, the conference is the largest of its kind in the world. [More Information on 2014 CSUN International Technology and Persons with Disabilities Conference]
RESNA 2013 Annual Conference
June 20, 2013 to June 24, 2013 in Bellevue, Washington, United States
Designed by and for people passionate about the use of assistive technology to improve the health and well-being of people with disabilities, RESNA 2013 offers educational sessions, scientific paper sessions, posters, three plenary sessions with internationally-recognized speakers, and a large exhibit hall. Mixed in are dozens of meetings of committees, SIGs (shared interest groups) and PSGs (professional specialty groups). [More Information on RESNA 2013 Annual Conference]
RESNA 2012 Annual Conference
June 28, 2012 to July 3, 2012 in Baltimore, Maryland, United States
The RESNA 2012 Annual Conference will be an interdisciplinary gathering of individuals and companies who share a common interest in rehabilitation engineering, assistive technology and disability issues in general. The conference schedule (to be announced at a later date) will include workshops and plenary sessions. Mixed in are dozens of meetings of committees, SIGs (shared interest groups) and PSGs (professional specialty groups). [More Information on RESNA 2012 Annual Conference]
News Return to top of page
Emergency Preparedness Survey
Dec 22, 2010
The Shepherd Center in Atlanta is conducting research on the use and usability of wireless technology by people with disabilities. They need volunteers to take an online survey before December 31, 2010. The survey is brief and you will be entered in a drawing to win a gift certificate. [More Information on Emergency Preparedness Survey]
Tots 'n Tech Needs Your Help!
Apr 18, 2006
The Tots 'n Tech Research Institute (TnT) is an inter-university collaboration between Thomas Jefferson University in Philadelphia, PA and Arizona State University in Tempe, AZ. TnT conducts a national research program about use of assistive technology (AT) to enhance the development of infants and toddlers with disabilities. A major component of the TnT's mission is to produce new knowledge and information about AT use and practices and, specifically, about the ways in which AT may optimize children's development and learning. TnT is currently conducting two surveys to learn more about how Assistive Technology (AT) may have been helpful to (1) parents and (2) infants and toddlers.The first survey, entitled "Family Survey," seeks information from parents whose children are under the age of three years on what kinds of training and experience the parents have had with AT. The second survey, the "Early Intervention Provider Survey," seeks information from multidisciplinary providers who work in early intervention at least one day per week to learn more about how AT may have been helpful to infants and toddlers. If you qualify as either a parent or a provider, please take a few minutes to respond to the appropriate survey. [More Information on Tots 'n Tech Needs Your Help!]


text:
I have never seen an ecoboost advertised to get 25 mpg. And it may with the AC off at 50 mph on flat ground. I know at 60 mph in my dodge hemi I am getting over 20
Sent from my iPhone newtys droid killer using Tapatalk
Results 31 to 39 of 39
Thread: new Tow Truck
11-09-2012, 03:14 AM #31David
2008 Mobius LSV, Gravity III , Wake Plate, Z5, Exile SX65c's, Exile XM9s, Exile XI12D, Exile Harpoon, Exile SM600.1 , Exile Xi800.4.
The 2011 commercials stated 22 mpg and the Ford website has the 2013 spec listed at 23 mph. I'll take either over the 15.7 my Silverado shows I'm getting today.
Sent from my iPad using Tapatalk HDDrew
New ride: 2012 Mojo
Old ride: 2008 OBV
Single cab 4x2 lol
Sent from my iPhone newtys droid killer using TapatalkDavid
2008 Mobius LSV, Gravity III , Wake Plate, Z5, Exile SX65c's, Exile XM9s, Exile XI12D, Exile Harpoon, Exile SM600.1 , Exile Xi800.4.
IDK i still think anyone claiming over 20 with a GAS full size truck is full of it. No way in Hell you will get that in Oregon.
No way since 06 they have changed the F150 so much as to get 8+ MPG better. That would be a 50% increase in milage just by changing an engine?
My 06 F150 got 12 in town and 16 on the highway. 4x4 Supercab wighed in at 6500lbs.
I have said before i know when i goto AZ i can get 20 in my Diesel on the highway and about 17 to 18 in town but its FLAT there.
I also havnt seen any modified Diesel get worse milage then a Gas truck, only exception would be the Chevy V8 that turns cylinders off to make it a 4 banger on the highway but that only works when there is no load on the truck
I also find it hard to believe a 3ton truck with a V8 is getting comperable milage to your average V6 car weighting in at 2 tons. IDK, the math just doesnt add up. More cyclinders more weight larger wind surface but equal mileage to a smaller engine, smaller windsurface and lighter vehicle.Last edited by mmandley; 11-09-2012 at 09:53 AM.
Malo <--- Means--Evil or Mean One. This explains a lot.
2013 Mojo 2.5 Skylon Tower. Bestia < Beast >
Exile ZLD
6 SX65M Cabins
6 XM9 Towers
1 XI Big 15 Woofer in a custom Fiberglass box
1 XI 1K Harpoon
2 Interstate 2400U 6V Golf Cart Batterties
Custom 1 Off Evolution Cover
Mikey I been watching them deals, I seen one few weeks ago 10k off msrp. The wife wants a new suv so I'm closer to having a suv sitting in the yard then a eco. lol
Mine shuts off 4 cylinders like the Chevy you mentioned under light loads. Ford has changed more than just the engine, they went from a 4 speed automatic to the 6 speed which saved fuel before the new engines came out, also the new innovations such as electric power steering and electric water pumps decreased engine load saving fuel. And yeah it's alot more flat down here tha. It is where you live.
I drove through the Texas hill country last week and at 50-60 mph I only got around 17 mpg due to all the ups and downs. The manufacturers mileage numbers are best case scenario meaning everything is ideal for optimal fuel mileage
Sent from my iPhone newtys droid killer using TapatalkDavid
2008 Mobius LSV, Gravity III , Wake Plate, Z5, Exile SX65c's, Exile XM9s, Exile XI12D, Exile Harpoon, Exile SM600.1 , Exile Xi800.4.
11-09-2012, 11:37 PM #37Senior Member
- Join Date
- Jun 2007
- Location
- Calgary Alta Canada
- Posts
- 893
As lots of you have mentioned, there are so many contributing factors. Speed, load, ac,on/off level road ,wind at your back , i did forget we are at pretty high elevation 3500ft so we lose power due to altitude as well. not quite as bad as Colorado? but close enough. I notice quite a difference when we go on holidays to places at lower elevations,with my boat so obviously truck is gonna do the same.
I guess in a perfect world , i'd get 25mpg but for now i will quit complaining and enjoy my ECOBOOST. As for hemi,s getting 20 i find that one a little hard to believe and as for cylinder deactivation again i call BS. Think about it .... How often do you really think they shut down? Under normal driving ? Thats next to never gonna happen. Maybe on a roller dyno with zero resistance under perfect conditions. Likely the same place Ford got there 25mpg number?07 Outback DD
I don't know guys, you all sound like you have it pretty good to me...
I live at 7000 ft and my drive to work and driving during the day takes me from 9000 and up to 12000, depending in which house I'm working at.
MPGs are not ideal, obviously, and I paid $4.60 per gallon today. At 35 gallons, that adds up. I do about one tank a week.
As I see it, you all get killer MPGs!!!'08 Mobius LSV, Mods- 1100 lb Rear Sacs, IBS Sac, Center 400 Sac, Dedicated thru-hull intakes and pumps per sac, SeaDek One Piece Mica over Black Roo, EZ Net Cargo Nets, Swivel Drivers Seat, Hot Water Shower, Hinged Wind Block, Bow Cushion Adapter Plate for Drink Holders Access, etc, etc.
As far as the 4 cylinder shut off at 70 mph it only does it on the down side of an over pass. At 60-65 mile per hour is cycles back and forth spending probably 70% only the time in 8 cylinder mode. It tells you when it does it so you can keep track.
As far as 20 mpg at 60 mph, my computer in the truck claimed 22.4 but I have hand calculated it out before and it lies by about 2 mpg pretty consistently so I just took it off the top and said 20. I didn't hand calculate it tho.
Sent from my iPhone newtys droid killer using TapatalkDavid
2008 Mobius LSV, Gravity III , Wake Plate, Z5, Exile SX65c's, Exile XM9s, Exile XI12D, Exile Harpoon, Exile SM600.1 , Exile Xi800.4.


text:
Troy Jacobson\'s Multisport Coaching Group is named the Official Coach of the Columbia Triathlon Association.
Since 1992, Troy Jacobson has been a leader and a pioneer in the field of multisport coaching. A former pro triathlete, sub 9-Hour Ironman Hawaii Finisher and three time Blackwater Eagleman winner.
Coach Jacobson is the creator of the world renowned Spinervals Cycling DVD Series, former member of the USA Triathlon Coaches Committee (1996) and founded the National Triathlon Academy in 1999.
His coaching results range from helping newbies finish their first event to training National Age Group Championship winners and Olympic Athletes.
A long time sponsor and supporter of Columbia Triathlon Association events, Coach Jacobson\'s Triathlon Academy will be offering specials on coaching services and products to CTA race participants including:
1. Personalized Coaching Programs
2. Discounts on Training DVDs
3. Discounts on Camps and Workshops
4. DVD of the Month Club Membership
5. Event-Specific Training Plans and much more!
A Special E-mail will be coming your way soon


text:
Motherwell left-back Steven Hammell remains hungry for success after signing a new two-year contract at Fir Park.
Motherwell defender Steven Hammell has been added to the Scotland squad for Tuesday's match with Croatia.
Danny Fox and Lee Wallace are the latest players to be ruled out of Scotland's World Cup qualifier in Croatia.
Motherwell defender Steven Hammell has been added to the Scotland squad for the World Cup qualifier against Croatia.
Stevie Hammell has praised Motherwell team-mate Michael Higdon for winning over the fans at Fir Park this season.
Stuart McCall does not expect there to be any problems as he prepares to sign an extension to his Motherwell contract.
Motherwell defender Steven Hammell says there was 'never any danger' he would move to another club after signing a new two-year contract.
Motherwell defender Steven Hammell is eager to commit his future to Fir Park for the remainder of his career.
Motherwell defender Stevie Hammell has signed a two-year contract extension at Fir Park.
Steven Hammell is aiming to retain his place in the Motherwell team to ensure he secures a new contract.
Steven Hammell has returned to Motherwell after completing a £110,000 move from Southend.
Southend have turned down an offer from Motherwell for defender Steven Hammell.
Watch every goal from every game in the Football League on your computer, mobile or tablet...


text:
Product Description
Available while supplies last.
Pertica Dining Chair (Set of 2)
With the unique T-Stitch back, softly padded seat and back, and overall comfortable upholstery, you simply can't go wrong with the Pertica Dining Chair.
- Espresso colored legs
- Seat cushion for maximum comfort
- Sturdy hardwood frame for stability and years of use
- Useful in the dining room or any other room as comfortable additional seating
- Set of 2
Finish: | Espresso | |
Materials: | Fabric/Bonded Leather/Wood | |
Usage: | Assembly Required | |
Assembly Required Some products are shipped to your door step assembled while others may require light assembly. | Assembly Required | Ready to Assemble |
Application | Residential | |
Distressed Finish Furniture distressing is the act of making a piece look as though it is worn out or antique. This style has become a very popular finish in the industry. Narrow your results here by whether or not you desire a distressed finish. | Distressed Finish | Non-Distressed |
Arms | Without Arms | |
Application | Indoor |
Dimensions & Weights
Width: | 24 inches |
Seat Depth: | 15½ inches |
Seat Width: | 17 inches |
Seat Height: | 19 inches |
BackToFront: | 17.7 inches |
Height: | 3 feet 3½ inches |
Coordinating Items
Related Items
Questions & Answers
There are no questions from the community yet
Customer Reviews
This product has no customer reviews yet
Write an online review and be the first to share your thoughts with other customers
Write an online review and be the first to share your thoughts with other customers
Product Support History
How often do people return this item?
How often does this arrive damaged?
Tag This Product
A tag is a keyword assigned to a product which helps describe the item and allows it to be found by other customers
Add a new tag:
Separate multiple tags with commas
What's this?Additional Details
Mfr Part # | |
Sku | |
Group # | 1107609 |
Category | Dining Chairs - 1473 |
Style | Transitional - 15 |
Sales Rank | 828 |
Your Recently Viewed Items
You have no recently viewed items. After viewing product detail pages or search results, look here to find an easy way to navigate back to products you are interested in.
Your Recommended Items
You currently have no recommended items. Browse a few more items to give us an idea of what you like.
©1999 - 2015
Copyright notice | Site Map | By using this site you agree to our Terms & Conditions of Use and Privacy Statement


text:
From Wikipedia, the free encyclopedia - View original article
Fred Kida | |
Born | Manhattan | December 12, 1920
Area(s) | Penciller, Inker |
Notable works | Airboy |
Fred Kida | |
Born | Manhattan | December 12, 1920
Area(s) | Penciller, Inker |
Notable works | Airboy |
Fred Kida (born December 12, 1920, New York City, New York)[1][2] is an American comic book and comic strip artist best known for the characters Airboy and Valkyrie.
Contents |
Born and raised in Manhattan, Kida attended New York City's American School of Design, where Bill Fraccio and Bob Fujitani were classmates.[3] Like many young artists in the Golden Age of comic books, he then broke into the field at the Jerry Iger Studio,[1] formerly Eisner & Iger, one of the earliest "packagers" that produced outsourced comic book content for publishers entering the new medium. Starting as an inker and background artist in 1941, Kida moved on to a staff position at Iger client Quality Comics.[citation needed] There he both penciled and inked his first known credited work, the feature "Phantom Clipper" in Military Comics #9 (April 1942).[4]
In 1942, he joined Hillman Periodicals, where he drew such features as "Iron Ace" (from its premiere in Air Fighters Comics vol. 1, #2, Nov. 1942),[5] "Boy King" and "Gunmaster", and the following year began work on his most prominent Golden Age character, Airboy. That aviation hero, created by writer Charles Biro with scripter Dick Wood and artist Al Camy, appeared initially in Air Fighters Comics, later renamed Airboy Comics.[4] Aside from Airboy himself, the feature was known for the sexy antagonist the Valkyrie, a cleavage-baring Axis aviatrix who soon defected and became his ally.[6]
Kida remained on the feature through 1948, afterward working with writer Biro on such Hillman crime comics as the seminal Crime Does Not Pay.[4] In 1953, he left to freelance for Atlas Comics, the 1950s forerunner of Marvel Comics. There he worked on characters including the Western gunslingers the Ringo Kid and the Two-Gun Kid and the medieval hero the Black Knight, plus horror, war and Bible stories.[4]
Kida returned to Marvel in the 1970s, primarily as an inker, working on such characters as Iron Man, Godzilla, Ka-Zar, Luke Cage and Man-Wolf, plus Captain Britain for Marvel UK. His final known full comic-book credit is the superhero-team title The Defenders #72 (June 1979) — featuring Marvel's Valkyrie. His last known published comic-book work was in the 1980s Eclipse Comics revamp of Airboy, to which he contributed a full-page pinup featuring both Airboy and Valkyrie.[4]
In addition to his comic-book work, Kida in 1941 was one of writer-artist Will Eisner's assistants on the newspaper Sunday-supplement comic-book The Spirit;[citation needed] and from 1946-47 assisted Fujitani (also known as "Bob Wells") on the comic strip Judge Wright.[citation needed] He also briefly assisted Milton Caniff on the strip Steve Canyon.[citation needed]
Most notably, Kida assisted artist Dan Barry on the long-running strip Flash Gordon from 1958–61 and then again from 1968–71;[4] and under his own byline, he drew the comic strip The Amazing Spider-Man during the early to mid-1980s.[7][8]


text:
Benefit Information
Eligible employees at Hamilton Center, Inc., enjoy a benefits package that offers many options.
Health Insurance: Includes vision screenings and prescription plan. A portion of the premium is paid by the Center. Employees have the coverage options of Employee only, Employee/Child(ren), Employee/Spouse, or Family.
Dental Insurance: A portion of the premium is paid by the Center. Employees have the coverage options of Employee only, Employee/Child(ren), Employee/Spouse or Family.
Guardian Vision Services: Allows employees to receive up to a 50% discount on glasses and/or contact from a list of participating providers.
Flexible Benefits Plan: Allows employees to pay for medical and/or dental premiums with pre-tax dollars. Also allows employees to set aside pre-tax dollars to pay for un-reimbursed or out-of-pocket medical expenses, and the dependent care (day care) expenses.
Life Insurance/Accidental Death and Dismemberment: Available at no cost to the employee. Amount of insurance is 2x employee's annual salary.
Retirement Plan: The center contributes 6% of an employee's gross earnings into a retirement account. Qualified employees of the Center become participants in the retirement plan on January 1 or July 1 following one year of employment. To be eligible, an employee must have worked at least 1,000 hours during the plan year.
403(b) Tax Deferred Annuity: Allows employees to contribute pre-tax dollars to a retirement savings plan.
Paid Time-Off: Combines traditional vacation, personal, and sick leave into one plan to provide eligible employees flexibility of time off. The amount of PTO that accrues each pay period beginning after 90 days is based on the employee's number of years of service and job classification. This time may be used, cashed out, or rolled over to the next year (limits or restrictions may apply).
8 Paid Holidays: Hamilton Center, Inc., recognizes the following paid holidays in addition to the PTO schedule: New Year's Day, Memorial Day, July 4th, Labor Day, Thanksgiving Day, Day after Thanksgiving, Christmas Eve, Christmas Day.
Tuition Assistance: Regular, full-time employees are eligible to be reimbursed up to $500 per semester ($10,000 lifetime) of the tuition costs of approved courses taken at approved institutions.
Long-Term Disability: A full-time regular employee is eligible on the 91st day of a non pre-existing extended illness for long-term disability insurance coverage. The Center provides the long-term disability coverage at no cost to the employee.
Short-Term Disability: A full-time regular employee is eligible for short-term disability beginning the 46th day of a non-occupational extended illness. The program provides monthly benefits after extended periods of disability caused by non-occupational injury or illness. The covered, eligible employee will receive a weekly benefit during the continued disability period from the 46th to the 91st day of a qualifying disability.
Benefit and Retirement Statement: Eligible employees will receive an annual personalized statement to help the employee with financial planning.
Other benefits also available include: Supplemental Life Insurance for employees and dependents, additional short-term disability protection, cancer expense protection, hospital intensive care plan, income security plus, and paid training, and assistance in obtaining Continuing Educational Units (CEUs).
These benefits are not meant to be exhaustive or to fully communicate the conditions and eligibility of each benefit. Please contact Human Resources for a complete description of any benefits option discussed.


text:
Coming up in the next {{countdown}} {{countdownlbl}}
Coming up next:
Skip to this video now
Now Playing:
Related Videos
Play Video
This transcript has been automatically generated and may not be 100% accurate.
A Pregnant Mother Enters Her Unborn Child into a Beauty Pageant
An English woman enters child in utero into a beauty pageant ? and she wins.
Baby Reacts to Mom's Singing
A 10-month old baby girl smiles and cries when mom sings Rod Stewart's "My Heart Can't Tell You No."


text:
Prestige Brands Inc. has added Little Colds Honey Elixir, a nonmedicated treatment for cough and sore throat, to its Little Remedies line of pediatric over-the-counter products.
Supplier News Breaks Archives
IRVINGTON, N.Y. – Prestige Brands Inc. has added Little Colds Honey Elixir, a nonmedicated treatment for cough and sore throat, to its Little Remedies line of pediatric over-the-counter products.
The company said Thursday that Little Colds Honey Elixir brings the benefits of natural honey to children ages 1 to 4, the group most often advised against taking medicated products for coughs or sore throat.
Many pediatricians are now recommending honey for their patients in the wake of a published study concluding that it may be a preferred treatment for the cough and resulting sleep difficulty associated with upper respiratory infection, Prestige Brands reported.
Little Colds Honey Elixir contains honey and other ingredients for a pleasant, sweet taste that makes taking the elixir easier for children who don't like the taste of most medications, according to the company. A teaspoon is recommended every two to four hours using the measuring cup provided with the product. Honey Elixir may also be used by children over age 4 in a dosage of two teaspoons.
"The incidence of cough is already higher this year than last among children under 5, according to the Fan Flu data reports in November," stated Jean Boyko, Ph.D., senior vice president of science and technology for Prestige Brands. "Little Colds Honey Elixir is on store shelves now, just in time for the cough and cold season, ready to fill the unmet need for children ages 1 to 4 who are advised not to take medicated products."
The Little Remedies line now offers four products for the treatment of cough and cold symptoms in children age 4 and younger, including Little Colds Safety Pops for sore throat irritation, Little Noses Saline for nasal congestion, Little Fevers for fever and pain relief, and the new Little Colds Honey Elixir (not for use in children less than one year old).


text:
Peruvian Chicken Ragout
From ksweas Report abuse
This recipe was submitted by a reader and has not been tested in our kitchen.
Be the first to rate this recipe
Save this recipe
Submit your version
You must be logged in to use this feature.
Username: | |
Password: | |
Forgot your username or password? |
Not a member? Register
Serves: 6
Total Time: 45 min
Prep Time: 20 min
Cook Time: 25 min
U.S. | Metric | Conversion chart |
- 1 pound(s) Chicken thighs, cut into 1 inch pieces
- 2 tablespoon(s) flour
- 1 teaspoon(s) chili powder
- 1 medium onion, chopped
- 1 clove garlic, minced
- 1 tablespoon(s) cooking oil
- 28 ounce(s) diced tomatoes
- 14 ounce(s) chicken broth
- 1 medium potato, diced
- 1 cup(s) frozen corn
- 1/2 cup(s) quinoa
- 2 cup(s) packed fresh spinach leaves
- 2 tablespoon(s) lemon juice
- Place chicken, flour, chili powder, 1/2 teaspoon salt, 1/2 teaspoon ground pepper into a plastic bag. Seal and shake to coat.
- In a 4 to 6 quart Dutch oven, cook chicken mixture, onion and garlic in hot oil until browned. Add undrained tomatoes, broth, potato, corn, and quinoa. Bring to a boil and reduce heat. Simmer, covered, 15 to 20 minutes or until potatoes and quinoa are cooked.
- Stir in spinach and lemon juice and cook just until spinach is wilted.
Loading photos...
Here are some alternate versions of this recipe created by our wonderful community of chefs!
More from Delish


text:
Vian man pleads not guilty to animal cruelty
SALLISAW, Okla. (AP) -- A Vian man accused of severely injuring a horse has pleaded not guilty to animal cruelty.
Rueben Ray Houston entered the plea Monday in Sequoyah County District Court. Houston is due in court again on March 19.
Prosecutors charged Houston with felony animal cruelty, misdemeanor trespass and misdemeanor malicious injury to property. He was arrested after an officer discovered a young horse tied to a tree.
A veterinarian testified that the animal was thin, malnourished and severely injured. The veterinarian said the horse's injuries were consistent with being dragged. The horse was eventually euthanized.


text:
News from the Bench
Discover what's going on at CST, receive our latest application notes and tips, read our science features, and learn about our products.
To get local purchase information on this product, click here
His-Tag (27E8) Mouse mAb (Sepharose® Bead Conjugate) #4079
This product is currently unavailable
YES! Alert me when the status of this product changes.
We recommend the following alternatives
8811 | His-Tag (27E8) Mouse mAb (Magnetic Bead Conjugate) | All |
Immunoprecipitation of extracts from COS cells transfected with a construct overexpressing Tyro3-His using His-Tag (27E8) Mouse mAb (Sepharose® bead conjugate) (lane 1). Mouse IgG Isotype Control (Sepharose® bead conjugate) #3420 (lane 2) was used as a negative control. The western blot was probed using His-Tag Antibody #2365.
Learn more about how we get our imagesProtocol
Product Usage Information
Application | Dilutions |
Immunoprecipitation | 1:20 |
Specificity / Sensitivity
His-Tag (27E8) Mouse mAb detects recombinant proteins containing the 6xHis epitope tag. The antibody recognizes the 6xHis-tag fused to either the amino or carboxy terminus of targeted proteins in transfected cells.
Species Reactivity: All Species ExpectedSource / Purification
Monoclonal antibody is produced by immunizing animals with a 6xHis synthetic peptide.
Epitope tags are useful for the labeling and detection of proteins using immunoblotting, immunoprecipitation, and immunostaining techniques. Because of their small size, they are unlikely to affect the tagged protein's biochemical properties.
Data Sheets & Documentation
For Research Use Only. Not For Use In Diagnostic Procedures. Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.


text:
My guest for today's episode of Cocknails is my husband, Robbie. So now you can all stop asking if I am married and what my husband looks like. It's ok with me, though, if you continually remind him how lucky he is to have nabbed a great catch like me. (If you can't see the video, click here.)
Here's the link to the original chevron nails tutorial.
And! AND! Guess what! Today is free shipping in my store! Get you a t-shirt and pay no shipping. Just use code XMASINJULY and a very merry Christmas in July to you!
If you liked this post, please pin it on Pinterest or share it where you hang out most! Share buttons are below to make it super easy! Thanks!


text:
Skip Links | Access/General | Site Map | |||||
Faculty of Arts and Social Sciences Lancaster University |
You are here: Home > | |||||
EventsNewsSubscribe to News and Events |
Religious Studies Seminars 2003-04Date: 1 October 2003 Week 1, Monday 7 October Dr John Shepherd 'Self-critical children of Abraham? Scripture and extremism in Judaism, Christianity and Islam?' Week 2, Monday 13 October Professor Pnina Werbner, Keele University 'Sufi Cults, Intimate Relations, and National Pakistani Networking in Britain' Week 4, Monday 27 October Professor Irven Resnick, University of Tennessee at Chattanooga 'Representations of the 'Other' Jew in Medieval Christendom' Week 6, Monday 10 November Dr Shabnum Tejani, SOAS 'Hindu Liberalism and Indian Muslim in the Debates Around Constitutional Reform, 1906-1909.' Week 8, Monday 24 November Dr Paul Fletcher & Dr C. Ram-Prasad 'Religion and Politics: Five theses on history and eschatology.' Week 10, Monday 8 December Dr Deborah Sawyer 'The power of Queen Vashti's 'no': the use of the female body in some biblical texts' Lent 2004 To be held in Room C.69, Furness College, Lancaster University. From 4.30 pm - 6.00 pm. Week 2, 19th January Dr Somdev Vasudeva, Wolfson College, Oxford 'Early Kaula tantra doctrine' Week 4, 2nd February Dr David Smith, Lancaster University 'Nietzsche's Hinduism' Week 5, 9th February Professor Bryan Rennie, Westminster College, Pennsylvania 'Eliade's Orientalism' Week 6, 16th February Dr Elizabeth De Michaelis, Dharam Hinduja Institute of Indic Research, Cambridge University 'A Deep History of Modern Yoga' Week 8, 1st March Dr Martyn Percy, Lincoln Theological Centre, University of Manchester 'Returning to "the Blessing": Charismatic Atrophy in Toronto Airport Christian Fellowship' Week 9, 8th March Dr Rachel Dwyer, SOAS 'The Gods in Indian cinema' Contact: Who can attend: Further informationOrganising departments and research centres: Religious Studies |
| Home | Departments | People | Study Here | Research | Business and Enterprise | News and Events | - FASS Intranet - |
Save this page: Del.icio.us Reddit Facebook Stumble It! |


text:
Back to Newsletters
July 2008 HCV Advocate
Download English printable version
Download Spanish printable version
The Future miRNAs? Alan Franciscus, Editor-in-Chief Durability of SVR Alan Franciscus, Editor-in-Chief Hepatocellular Carcinoma Liz Highleyman HealthWise: Hepatitis Seeing Lucinda Porter, RN PROVE 3-Interim Results Alan Franciscus, Editor-in-Chief HCV Advocate Eblast Stay informed on the latest news ..click here to register for email alerts
Back to top The Future – miRNA's ? Alan Franciscus, Editor-in-Chief
There has been a lot of news about a new class of drugs that can potentially treat a wide variety of conditions and diseases. Surprisingly, one of the biggest news stories about this new class of drugs has hardly made a splash. That news is that the first microRNA or miRNA compound went into human testing and it is being studied to treat hepatitis C. The compound, SPC369, is being developed by Santaris in collaboration with GlaxoSmithKline. The clinical trial will enroll a maximum of 48 healthy male volunteers to test the safety, tolerability, and pharmacokinetics of SPC369. The company reported that one group of the study participants has already completed treatment satisfactorily.
SPC369 specifically targets microRNA-122 – a chemical that has been shown to assist in the replication of the hepatitis C virus in liver cells. Inhibiting microRNA-122 could potentially stop the replication of HCV.
The discovery of microRNAs and their potential as therapeutic agents for a wide variety of conditions has a long and interesting history that started back when the Human Genome Project was launched in 1990 by the U.S. Department of Energy and National Institutes of Health. The goal of the Human Genome Project was to identify all of the genes in human DNA and to determine the sequence of approximately 3 billion chemical base pairs that make up human DNA. The original goal was to identify all human DNA genes in 15 years, but because of rapid technological advances over the years, the project was able to meet the goals and to identify all the human DNA genes in 13 years.
The Human Genome Project was able to map approximately 25,000 protein-coding genes, but this is only 1.9% of human DNA. The remaining DNA was labeled as "dark" or "junk" DNA and was thought to be of no particular importance. However, scientists at Rosetta Genomics believed differently and were able discover and patent some 35 viral microRNAs.
MicroRNAs are short naturally occurring, single-stranded RNA molecules that do not code for protein, but instead attach to messenger RNAs to suppress their function. Inhibition of microRNAs could potentially interfere with the viral replication and/or the disease process.
In addition to being tested to treat hepatitis C, microRNAs also are being looked at to treat many other diseases and conditions including HIV, cardiovascular disease, muscle disorders, and liver cancer. These new drugs, however, are only in the initial stages in the development cycle so we don't know yet how effective they will be or what type of side effects might result after taking these medications. Still, the potential of these new drugs is so exciting because they could be used to treat so many diseases and conditions. Back to top Durability of SVR Alan Franciscus, Editor-in-Chief At the recent 2008 Digestive Disease Week (DDW) conference two posters were presented on the long term clearance of HCV and disease progression in people who had achieved a sustained virological response (SVR) – defined as HCV RNA negative 24 weeks post antiviral therapy.
The two studies compiled data from previous studies of PegIntron with or without ribavirin in adults and children. The aim of the studies was to find out if the people who achieved an SVR were still HCV RNA negative (after more than 5 years) and the effect an SVR had on the histology or health of the liver.
Durability in Adults In the first poster K.L. Lindsay and colleagues studied the durability issue as well as the ability of an SVR to halt or slow disease progression.
The study participants were taken from 2 large, international clinical trials of patients who had received either PegIntron monotherapy or the combination of PegIntron plus ribavirin. In order to be eligible for the study, trial participants had to have completed 24 weeks of follow-up in one of the 2 initial studies and were also required to enroll in the current study anytime between 1.5 to 5.5 years after treatment. In addition participants were not allowed to receive any HCV medications while enrolled in the current study. Participants were also evaluated for clinical evidence of liver disease progression. The viral load tests were able to detect low levels of HCV RNA: <125 IU/mL (PCR-TaqMan) and <50 IU/mL (COBAS TaqMan).
In all, 33% (567 of 1695 patients) of eligible participants were enrolled in the long-term follow-up study. Of these, 366 patients were considered sustained responders and 201 were considered non-responders (control group). This article will only report on the study participants who had been followed for at least 5 years. Sixty-two percent (227 of 366 patients) who achieved an SVR were followed and it was found that only 4 participants (1%) in this study relapsed (became HCV RNA positive) during the 5-year follow-up period. It was also found that there was no clinical progression of liver disease during the long-term follow-up period. Only 1 person in the non-responder group was found to have clinical progression (bleeding varices) of HCV. The authors concluded that "Attainment of SVR after treatment with PEG-IFN alfa-2b, with or without ribavirin, predicts long-term clearance of HCV."
Durability in Children In the other poster, K. Kelly and colleagues reported on the durability of SVR in children. Sustained virological response was defined as above and the trial included children between the ages of 3 to 16 years who were treated with PegIntron/ribavirin (dosed by body weight). The study design, and criteria for the detection of HCV RNA were the same as in the study above. The children were also evaluated for clinical evidence of liver disease progression.
In total 58% (97 of 166 patients) were included in the study and 75% of the sustained responders completed 5 years of follow-up. In the children who achieved an SVR, 98% remained HCV RNA negative 5 years after the completion of therapy – only one child relapsed during this period. In addition there was no evidence of clinical progression of liver disease in the children who achieved an SVR.
The authors concluded that "Attainment of SVR after treatment with IFN alfa-2b and RIBA [ribavirin] predicts long-term clearance of HCV in pediatric patients."
Bottom Line The current studies and previous studies conducted by Roche also support data from other studies that have found that up to 99% of people who achieve an SVR remain HCV RNA negative for at least 5 years after the completion of therapy. Hopefully, the studies conducted by Roche and Schering will continue to follow the people in their trials over time to confirm these findings and to improve our understanding of the durability of an SVR. Back to top Hepatocellular Carcinoma Liz Highleyman Over the course of years or decades, people with chronic hepatitis C or B virus (HCV or HBV) may develop advanced liver disease, including hepatocellular carcinoma (HCC). HCC is the most common type of primary liver cancer, meaning it originates in the liver, rather than metastasizing (spreading) from elsewhere in the body.
Epidemiology With an estimated 21,000 new cases in the United States in 2008, HCC accounts for less than 2% of all cancers. But its incidence has risen sharply over the past two decades as people infected with HCV many years ago began to reach advanced stages of disease; experts estimate that as many as half of U.S. primary liver cancer cases are now associated with hepatitis C.
HCC is much more common in other parts of the world, such as Asia and Africa, due to endemic hepatitis B infection and environmental exposures; worldwide, nearly 600,000 new cases are diagnosed annually.
Who Is at Risk? Only a small minority of people with chronic viral hepatitis will develop HCC over a lifetime, and it is difficult to predict in advance who these will be. The disease is significantly more common in men compared with women, and usually occurs after age 50.
About one-quarter of people with chronic hepatitis C or B progress to liver cirrhosis (scarring), and an estimated 5% of these develop HCC. Researchers think this happens as long-term liver injury leads to tissue regeneration, eventually resulting in uncontrolled proliferation of hepatocytes (liver cells).
HCC is most likely to occur in people with active HCV or HBV replication, as indicated by detectable HCV RNA or HBV DNA viral load. Its connection with specific viral genotypes is unknown.
Liver cancer seldom occurs in hepatitis C or B patients without cirrhosis. HCC typically develops 20 to 30 years after HCV or HBV infection, though it may occur as soon as five years after exposure. People with both HCV and HBV, and those with HIV coinfection, tend to experience more rapid liver disease progression.
HCC can also be caused by other forms of liver damage, including alcoholic liver disease, hemochromatosis (iron overload), and inherited metabolic disorders. There is growing evidence linking obesity, insulin resistance, and diabetes – which are associated with liver steatosis (fat accumulation) – to liver cancer. Exposure to aflatoxin, a substance produced by mold on poorly stored nuts and grains, is also a risk factor.
HCC Prevention Since people with chronic hepatitis C or B who do not have cirrhosis usually do not develop HCC, antiviral therapies that slow or halt fibrosis progression can reduce the risk of liver cancer.
Several studies have shown that chronic hepatitis C patients who achieve sustained virological response (SVR) to interferon-based therapy are significantly less likely to develop HCC – three-fold less likely over five years in one recent study. Though data are inconsistent, some research suggests that even people who do not achieve complete HCV eradication may still benefit. But in the recent HALT-C trial, prior nonresponders to pegylated interferon (Pegasys or PegIntron) plus ribavirin who received low-dose Pegasys maintenance therapy for three years were no less likely to develop HCC than those who received no further treatment (about 3% in both groups).
Symptoms Detection of HCC is difficult because most people have no symptoms during the early stages. As the cancer progresses, people may experience malaise, loss of appetite, fever, and fatigue, but these are signs of liver disease in general, not specifically HCC. Liver cancer patients commonly present with symptoms of cirrhosis, including jaundice, ascites (abdominal swelling), and portal hypertension. Some people experience pain in the upper right part of the abdomen, and sometimes the liver is enlarged or a tumor can be felt from outside the body.
Screening Since HCC is most easily treated when it is detected early, people at high risk should receive regular monitoring. The most frequently used biomarker screening test for HCC measures the alpha-fetoprotein (AFP) enzyme. The test is inexpensive and easy to perform, but has a high rate of false-negative and false-positive results. Many people with early-stage liver cancer have normal AFP levels, and elevated levels can signal conditions besides HCC, including hepatitis flare-ups, testicular cancer, and pregnancy. Other blood biomarkers for HCC are currently under study.
Imaging scans are also used for HCC monitoring. Abdominal ultrasound is relatively simple and inexpensive, but not very accurate. Computed tomography (CT) and magnetic resonance imaging (MRI) are used to detect liver tumors, and some techniques can determine blood flow in major liver arteries and veins. Angiograms, which show patterns of blood vessel growth, can also reveal tumors. All these methods, however, may fail to detect small tumors.
Liver biopsy remains the "gold standard" for definitely diagnosing HCC, since microscopic examination can distinguish malignant tumors from benign growths. In practice, a diagnosis of HCC is often made without a biopsy if a patient with cirrhosis has a high AFP level and a growing mass on consecutive imaging tests.
Most experts recommend that people with cirrhosis should be screened for HCC every six months to one year. Less frequent monitoring is considered sufficient for non-cirrhotic people with HCV or HBV. But since it can be difficult to determine the exact extent of liver damage without repeated biopsies, some clinicians favor screening people with significant fibrosis. Studies have shown that a combination of AFP and imaging can detect smaller tumors and improve survival in high-risk patients, but the cost effectiveness of HCC screening remains unclear.
Staging Once cancer is detected, it is staged to determine the size, number, and location of tumors, the extent of metastasis beyond the liver, and involvement of blood vessels. HCC is usually classified as localized resectable (a single tumor that can be completely removed), localized unresectable (localized cancer that cannot be completely removed due to its location or the medical condition of the patients), or advanced (cancer that has spread to both lobes of the liver, nearby lymph nodes, or other parts of the body). Several different staging systems are used, including the "TNM" and the "CLIP" methods.
Treatment Although therapies for HCC have improved in recent decades, it remains among the most difficult cancers to treat. Choice of treatment depends on characteristics of the tumors, whether the cancer has spread outside the liver, and the overall health of the patient; prognosis may depend more on a person's liver function than on features of the cancer itself. Since it is usually detected late, survival is typically measured in months, but individuals who are diagnosed early have better outcomes.
Resection If tumors are small (less than 5 cm), few, and confined to a limited area of the liver, the cancer may be completely removed by surgery, known as hepatic resection. The surgeon may remove a wedge of liver tissue, an entire lobe, or even more, since the liver can regenerate itself. This method is highly effective when appropriate, but only 10% to 20% of HCC patients have completely removable tumors. In addition, some malignant cells may be left behind, leading to recurrence.
Transplantation Liver transplantation may be another option if the cancer has not spread elsewhere in the body. This approach also offers a potential cure, but the supply of donor livers is extremely limited and patients must be in good enough health to withstand surgery. Outcomes are best for individuals with small tumors, and therapies to shrink tumors may be used while a person is on the waiting list.
Ablative Therapies If the cancer cannot be completely removed, various "ablative" therapies may be used to destroy or shrink tumors in place. Radiofrequency ablation (RFA), for example, uses an electrode probe to deliver a current that heats the tumor; newer thermal methods use microwaves or lasers.
Other ablation methods include percutaneous ethanol or acetic acid injection (substances are injected into the tumor to poison the cells), cryosurgery (freezing the tumor with liquid nitrogen), and radiation. Typically, this involves injecting tiny beads containing radioactive material (TheraSphere) into the liver; another method, the CyberKnife, delivers a focused beam of radiation to the tumor.
Transarterial chemoembolization (TACE) involves blocking the hepatic artery and injecting chemotherapy drugs directly into the tumor's blood supply – a method that causes fewer side effects than systemic chemotherapy.
Combinations of therapies tend to produce better results. Chinese researchers recently reported, for example, that patients who underwent both TACE and RFA lived longer than those treated with either method alone (37 vs. 22-24 months).
Systemic Chemotherapy If cancer has spread beyond the liver, systemic chemotherapy may be tried, but outcomes are generally poor because HCC is relatively resistant to drugs, and patients with advanced liver disease may be unable to tolerate side effects. However, investigators with the SHARP trial recently reported that sorafenib (Nexavar), a drug newly approved to treat unresectable HCC, improved survival compared with placebo in patients with advanced liver cancer.
Hope for the Future With all these approaches, outcomes are best in younger patients with better preserved liver function whose HCC is less advanced. While response rates may approach those of resection surgery – up to 80% under ideal circumstances – ablation and chemotherapy are considered palliative rather than curative.
HCC remains difficult to treat, but regular screening can detect the disease at an earlier stage. Treatment approaches have improved considerably in recent decades, and patients who participate in clinical trials have the first chance to benefit from experimental therapies.
Ultimately, the best "cure" for HCC is prevention of underlying liver disease, and there is good reason to hope that more widespread hepatitis B vaccination and improved treatments for hepatitis C and B will reverse the recent upward trend in liver cancer.
References Cheng, B-Q. et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm. JAMA 299(14): 1669-1677. April 9, 2008.
Di Bisceglie, A.M. et al. Prolonged antiviral therapy with peginterferon to prevent complications of advanced liver disease associated with hepatitis C: Results of the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C) Trial. 58th Annual Meeting of the American Association for the Study of Liver Diseases. Boston, MA. November 2-6, 2007. Abstract LB1.
Galle, P. et al. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and prior anti-tumor therapy: a subanalysis from the SHARP trial. 43rd annual meeting of the European Association for the Study of the Liver. Milan, Italy. April 23-27, 2008.
Hung, C.H. et al. Long-term effect of interferon alpha-2b plus ribavirin therapy on incidence of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. J Viral Hepatitis 13(6): 409-414. June 2006.
Taura, N. et al. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma. Clin Gastroenterol Hepatol. 4(9): 1177-83. September 2006. Back to top HealthWise: Hepatitis Seeing Lucinda Porter, RN
No organ is more important than any other, but try to convince us of that when it comes to our eyes. This point was demonstrated recently when a patient I was working with developed vision problems. Six months earlier he had completed hepatitis C (HCV) treatment. Naturally he wondered if there was a correlation between his eye condition and the treatment.
His liver specialist and other experts in the field did not believe there was a correlation in this particular case. Eye diseases are common, particularly as we age. According to the National Eye Institute (NEI), in the 2000 U.S. census there were more than 119 million adults over age 40 with age-related eye diseases. This number is expected to double in the next three decades. Some eye conditions are associated with HCV. The most common of these is dry eye syndrome. HCV treatment may cause or worsen some eye problems. Corneal ulcers are associated with HCV and its treatment. Prescription information for peginterferon-alpha with ribavirin warns of ophthalmologic (eye) disorders such as decreased, blurred or loss of vision, retinopathy including macular edema and retinal thrombosis/hemorrhages, optic neuritis and papilledema. Let's discuss these and other terms.
Courtesy of the National Eye Institute – www.nei.nih.gov
The outer most layer of the eye is the cornea. Ulcerations on the cornea may be caused by a variety of factors, HCV being one of them. One example, Mooren's ulcer is discussed in the HCV Advocate's Medical Writers' Circle's Extrahepatic Manifestations of Chronic Hepatitis C, by Remoroza and Bonkovsky.
Retinopathy refers to retina problems. The retina is a nerve-rich area in the back of the eye. It receives light and transmits images to the brain. Many factors cause retinopathy. People with high blood pressure or diabetes have a higher risk for retinal problems. White puffy spots on the retina are called cotton wool spots and may indicate nerve damage. A retinal thrombosis is a blockage in one of the retinal vessels. A retinal hemorrhage is a bleeding vessel. Treatment-related retinopathy usually ceases after medication is stopped.
The macula lies near the center of the retina. It is responsible for clarity of sight. Macular edema means that there is swelling caused by fluid accumulation.
Optic neuritis is swelling of the optic nerve. This nerve transmits information from the retina to the brain. The head of the optic nerve is the optic disc. If the disc swells due to an increase in pressure from the brain or spinal fluid, the result is known as papilledema.
When undergoing HCV treatment, report eye problems immediately. Many of these problems turn out to be minor, often caused by dry eyes or even fatigue. However, since some eye problems can contribute to permanent vision impairment, let your doctor evaluate the situation.
Dry eye syndrome or keratoconjunctivitis sicca is common, more so in people with HCV. It can be caused by insufficient or improper tear production or when tears evaporate too quickly. Inflammation may accompany dry eyes. This condition may be uncomfortable or painful. Ulcers, scars, and even vision loss may occur if dry eye syndrome is not treated.
Certain factors may intensify dryness, such as air travel, dry climates, menopause, and some medications. Antihistamines, decongestants, antidepressants, tranquilizers, estrogen and interferon may cause eye dryness. Some people develop dry eyes after vision surgery, such as the Lasik procedure.
Eye dryness is associated with other diseases, particularly autoimmune disorders. Those with HCV have an increased risk of autoimmune disease, so your medical provider may want to rule out other causes before assuming that dry eyes are related solely to HCV.
Treatment of dry eyes begins with understanding the cause of the problem. Over-the-counter tear replacement drops or ointment may be suggested. Choose preservative-free artificial tears if you use them more than 4 times daily. Avoid sun and glare. Use sunglasses that wrap around your head and block out UVA and UVB rays. Your specialist may suggest a dietary supplement, such as omega-3 fatty acids. Since too much or too little of certain vitamins may contribute to dryness or other problems, do not take a supplement without first discussing it with your medical provider. Your eye specialist may prescribe medication or recommend plugging your eyes' tear drainage holes.
Your HCV medical provider may know something about eye diseases, but you should see an eye specialist to manage these. Unless you have a severe problem or need surgery, you will likely see a doctor of optometry (O.D.). Optometrists have 4 years of advanced training in their field. Although they are not physicians, optometrists can prescribe medication and handle most eye problems except surgery. If the problem is more complicated, you may be referred to an ophthalmologist (M.D.). This specialist has attended medical school and can perform surgery. If you need glasses, you may see an optician. This professional dispenses glasses and in some states, contact lenses, but does not treat eye diseases.
Patients should have a baseline eye exam prior to beginning HCV treatment. Those with diabetes or hypertension should consult with an ophthalmologist before treatment. Patients with multiple health conditions, such as HIV and diabetes, need close monitoring during HCV treatment.
HCV patients who need a liver transplant are at risk for post-operative eye infections that may occur in all post-transplant situations. Post-transplant patients with vision or eye problems are encouraged to report these immediately.
Eye problems are a concern for those living with HCV, but can occur in anyone. In spite of the numbers, many of us are tempted to blame every ache and pain on hepatitis C. It is a natural response to living with a chronic disease. Others operate in the opposite extreme and deny having any aches or pains of any cause. Learning to live somewhere in between is sensible. It takes knowledge and practice to navigate illness. While you are practicing, keep your eyes wide open.
Vote Health A very exciting election is taking place in the midst of these rocky times. Rock the Vote is a campaign to get out the youth vote. This is good, but Baby Boomers are the original Rock generation and are facing Medicare shortfalls. Baby Boomers need to rock the vote too – for the country's health as well as their own. www.rockthevote.com/home.html Back to top PROVE 3-Interim Results Alan Franciscus, Editor-in-Chief
On June 9th, Vertex released very promising data from their PROVE3 clinical trial. PROVE3 is a phase II clinical trial using telaprevir combination therapy to treat people with HCV genotype 1 who had been previously treated with pegylated interferon plus ribavirin, but who did not achieve a sustained virological response (SVR).
In this phase II study, the patient population included treatment non-responders, treatment relapsers and people who had a viral breakthrough while on therapy. The trial participants received 12 weeks of telaprevir in combination with Pegasys plus ribavirin followed by an additional 12 weeks of therapy with Pegasys plus ribavirin (without telaprevir). The total treatment duration in the telaprevir arm was 24 weeks.
The control arm also consisted of HCV genotype 1 patients previously treated with pegylated interferon plus ribavirin who were deemed treatment nonresponders, relapsers, and breakthoughs. The patients in the control arms were treated with Pegasys plus ribavirin (without telaprevir) for a treatment duration of 48 weeks. Since the treatment duration of the control arm is 48 weeks the SVR12 and other SVR rates are not available.
The patient population of the group that received the telaprevir combination therapy comprised prior non-responders (66 patients), relapsers (40 patients) and breakthroughs (9 patients). The SVR 12 (undetectable HCV RNA twelve weeks after therapy ends) results for the arms that received telaprevir are given in the table.
It was noted that the side effects reported in this study were similar to the side effects seen in previous studies of pegylated interferon, ribavirin, and telaprevir.
Successful treatment results from HCV therapy is usually defined as sustained virological response or SVR – that is undetectable HCV RNA 24 weeks following the completion of therapy. The preliminary results reported in the press release are SVR12 results – undetectable HCV RNA 12 weeks following the completion of therapy. In previous studies of telaprevir, the SVR12 results have been in line with the regular results reported 24 weeks following the completion of therapy.
In addition to the study arms listed above, there were two additional arms, one of which included a 24-week arm of telaprevir without ribavirin, and the other a 48 week treatment arm that included 24 weeks of telaprevir in combination with pegylated interferon and ribavirin. Vertex reported that the interim results from these two arms support the use of ribavirin and that the use of telaprevir beyond 12 weeks does not provide additional treatment benefit. It was also noted that the dosing for all the patients in PROVE3 has been completed.
The final results for all arms of the study are expected to be released at the AASLD 2008 Conference.
Vertex in collaboration with Tibotec also announced that a phase III study is planned for the third quarter of 2008 to examine the use of telaprevir in combination with pegylated interferon plus ribavirin in HCV genotype 1 patients who failed to achieve an SVR with pegylated interferon plus ribavirin. According to the press release, treatment duration will be 48 weeks – 12 weeks of telaprevir, pegylated interferon, and ribavirin followed by 36 weeks of pegylated interferon plus ribavirin, but without telaprevir (total treatment duration of 48 weeks). Visit www.clinicaltrials.gov for information about HCV clinical trials that are actively recruiting patients.
Bottom Line These results are the highest yet seen for the re-treatment of people who have not been able to achieve an SVR with pegylated interferon plus ribavirin therapy. It goes without saying that these results are very encouraging and brings hope to people who are in need of treatment.
Hopefully, the new phase III study will yield even more good news and perhaps even higher response rates. Back to top Back to Newsletters
About Hepatitis | News Updates | Community & Support | Resource Library | About HCSP | Contact Us | Site Map | Recursos en Español | Home (C) 2008. Hepatitis C Support Project


text:
fifa 2007 download full game (59 programs)
Articles fifa 2007 download full game
How to use WhatsApp on Windows
UPDATE: WhatsApp has come out with an easy way to chat from your computer. It's called WhatsApp Web... See more
Windows more secure than OSX? Not so fast.
A report published by GFI Software, a security software developer, revealed which operating systems... See more
5 Ways to Breathe New Life into Dying Light
While Dying Light's popularity was undoubtedly buoyed by it being the only big budget titles released... See more
Related videos fifa 2007 download full game
FIFA 14 - Best Goals of the Week - Round 1
First of a video series about best FIFA 14 goals.
PES 2014 - Trailer - PES Competitions
PES 2014 new trailer focuses on the game competitions.
FIFA 14 - All New Celebrations Tutorial
In this video you'll find all the new celebrations you'll be able to perform in FIFA 14 and how to activate them.


text:
By: heron55 on July 5, 2011 - 7:51am - Add new comment
This cat learned to blend into the surroundings, but is evidently color blind. Must be flea spray time again to hide.
By: heron55 on July 3, 2011 - 12:26pm - Add new comment
I think this is funny. Paula who lives on the waterfront on Wilmington Island in Savannah, wants to raise her own chickens. But the zoning is not for agricultural use, so she was given a ticket.
Seems she has some sympathy from some others who have a garden, which is OK as long as it is not commercial, but some others also want to raise a few chickens, but can't, unless they live is a rural area where zoning doesn't allow it.
By: heron55 on June 30, 2011 - 4:48pm - Add new comment
In an article in CNBC of all places, Mr Greenspan is said to testify that the stimulus did little good and actually did harm. Nice to have a confirmation that conservatives have said all along. And now we have Obama asking for more stimulus. Will they ever learn? Ok, they will when we can't borrow any more.
By: heron55 on May 25, 2011 - 6:59am - Add new comment
This view of the space shot is unsual as we see it above a cloud formation. See the link for a better picture
By: heron55 on May 16, 2011 - 8:29am - Add new comment
For the latest in pet fashion, take note of the latest bling.
By: heron55 on May 9, 2011 - 8:57am - Add new comment
This is a secret photo of the practice session for the raid on Osama's lair. Notice that Obama has the game controller manupulating the seals as they attack the compound while military suits watch. Practice, practice, practice.
By: heron55 on May 2, 2011 - 6:21pm - Add new comment
OK, so Osama takes the news headlines lately. But remember just a month ago, the libs were in arms over the GOP in Wisconsin trying to balance their state budget by removing the collective bargaining rights of government employees. It even got to smoking here on the BT blog.
Even the candidate for the state supreme court was making national headlines.
But now the Massachusetts house has voted to do the same thing on 4/27. It's not passed yet because it goes to the senate.
By: heron55 on April 27, 2011 - 7:15am - Add new comment
One of the events I look forward to each year is the Spoleto and Piccolo Festival each year in Charleston. It is two weeks of entertainment with a wide range of events in the arts. Plays from modern to Shakespeare, art shows, ballet, music from modern jazz to the baroque and classicals, and craft shows. The Spoleto part are national and international artists and groups and the events are pricey, but being performed here rather than New York or other large city. The Piccolo is the same, but with less artists less known in our region.
By: heron55 on April 26, 2011 - 7:46am - Add new comment
Scientists have been trying to find the smallest particle in the universe that theoretically is the building block for all matter. The CERN Large Hadron collider in Switzerland is the location of the large and expensive lab. But a leaked memo, later found to be false or at least misleading, said they had found the existence of the Higgs boson, a name given to the yet to be found particle.
If you can figure out what the memo said, you have more brains than me. But just for the fun of it, see if you can read this memo:
By: heron55 on April 14, 2011 - 5:39pm - Add new comment
Just for the Tim Wood fans, I ran across an opinion piece by him in the LowcountryWeekly. (Except it is poublished every other week) He has his email there if you want to contact him. Best of luck, Tim.


text:
Content tagged with "directory"
A faster page means a better user experience, so as part of our ongoing improvements to the site and to remove a potential server issue (perhaps related to our recent server issues), I've just written some code to improve select caching of remote content such as the search dropdown, the Administration section and many of the "Contact Us" sections that appear directly beneath each site's navigation and faculty information that is auto-filled on faculty pages. …
How to create a new directory
What to do if you forget your directory password.
Instructions on how to restore a directory
Working with the File Browser
As we continue to link up services to core data resources, we are adding department/office/program contact information to search results when they turn up as recommended results in the search engine. We used "english" as a test case here, so now if you do that very search you'll now see basic contact information for Academic English Studies and the Department of English. The linking process is a manual one, so we'll be working through many others in the week…
We recently made a few more updates to the search engine to improve the find-ability of faculty information. We link to LiveWhale faculty pages. Every night, we refresh our people data from Colleague (Lewis & Clark's central people database). We get all kinds of contact and basic information about everyone directly associated with Lewis & Clark, like current faculty, staff and students. For faculty, we know that many if not all professors (i.e. not…
You may have noticed there's a new link in the institutional (meta) navigation at the top of the page. This is a new feature of the website that we've been working on for a little while and is our first step into building organizational data into our sites. http://www.lclark.edu/administration/ Clicking Administration takes you to a web page that is written for a diverse outside audience, since we expect that this link will be used by people that haven't y…


text:
Friday, April 13, 2012 - 7:35am
RIO GRANDE VALLEY - The journey into America illegally can be a dangerous one, but it's a journey thousands of people make every year. The U.S. Border Patrol says many times these immigrants go to unhealthy and life threatening risks.
News Center 23 Reporter Erin Murray walked through the brush with Border Patrol to see what illegals go through to cross over.


text:
You won't be able to dismiss this by usual means (escape or click button), but you can close it programatically based on user choices or actions.
"The invites were exactly what I saw in the proof, and I was very pleased with my order! I will definitely be keeping this in mind when my other friends get married (and other occasions!)."
"I just received my bachelorette invites and they look great! The design process was simple and easy. Not all of the wording would fit into the space provided - the design team made the adjustment for me and I was sent a proof of the adjustment within 24hrs. Shipping was quick and painless. Overall great experience with Wedding Paper Divas, I will order from them again!"
"This was a perfect bachelorette invitation. Great quality, classy, cute. I got lots of compliments from the party guests. Very impressed :)"
"I ordered these for my sisters bachelorette weekend and we loved them! So many compliments, they were a really good quality invitation."
"These cards are amazing! They came out beautifully! I ordered them in purple and I just can't express how beautiful they were! Very impressed with quality, color, design the works. They were a huge hit."


text:
Cayman Islands Winter Break Program Courses
Week 1
(Dec. 27, 2014 - Dec. 30, 2014)
Asset Protection Trusts in the Caribbean (1 credit)
Instructor: Carla Spivack
Offshore Asset Protection Trusts (OAPTs) are an increasingly popular device for "high risk" people – real estate developers, corporate directors, doctors, lawyers, and others perceived to have "deep pockets" - to protect their assets from creditors. The islands of the Caribbean, including the Caymans, are a major situs for these trusts, which may also offer tax and other advantages. This is an important area of law for estate planners and others in banking, regulatory and tax law.
This course will cover the basic law governing these trusts in the Caribbean in four units: 1) considerations in locating the OAPT, such as the jurisdiction's fraudulent conveyance laws, its rules of comity, Rule Against Perpetuities repeal in the jurisdiction and its effects, the offshore tax laws and how they differ from the U.S. tax law of trusts, and the jurisdiction's confidentiality rules; 2) features of OAPT instruments which are designed to ward off creditor claims and how to draft them, such as anti-duress clauses, protective trust clauses, and discretionary distribution clauses; 3) an assessment of the legal challenges to OAPTs through the reading of cases which have tested the legal status of OAPTs; and 4) ethics considerations involved in advising clients about OAPTs.
Comparative Intellectual Property Law (1 credit)
Instructor: Darryl C. Wilson
This course will provide a survey knowledge of Intellectual Property (IP), comparing the US system, with the laws of the CARICOM member states, both independently as well in connection with the CARICOM treaty. We will also compare the nations laws and treaty language with the Agreement on Trade Related Aspects of Intellectual Property Rights (TRIPS). TRIPS is the pre-eminent treaty setting forth the minimum standards for IP throughout the world with approximately 160 nations currently signatories.
I foresee the first day as an intro to IP concepts around the world. The second day as an intro on the interplay of national laws, pluralateral treaties (i.e. CARICOM), and multilateral treaties (i.e. TRIPS). The third and fourth days as a focus on dispute resolution options available to individuals and nations as well as the needs of the region to develop a multinational IP office. The exam will be 50 MC questions.
Week 2
(Jan. 2-5, 2015)
Human Rights in the Commonwealth Caribbean (1 credit)
Instructor: Deborah Barker Roye
The course will explore the mechanisms for, and effectiveness of, the protection of human rights in the Commonwealth Caribbean, both the Independent Commonwealth Caribbean Islands and the British Overseas territories including the Cayman Islands.
The following rights will be explored: Right to Life, Right to Protection from Torture and Inhuman or Degrading Treatment, Right to Personal Liberty, Right to a fair trial, Right to Private & family life, Conscience and Religion and non-discrimination.
Climate Change Impacts on Ocean and Coastal Law (1 credit)
Instructor: Randall Abate
The course will address how climate change impacts are shaping domestic and international law responses to the management of oceans and coastal areas. Topics will include sea level rise, coastal erosion and beach renourishment, ocean acidification, impacts to fisheries and endangered species, ocean iron fertilization, and human rights dimensions of coastal adaptation. The course will also include a unit on climate change impacts on Caribbean nations' ocean and coastal resources.


text:
Ultra-luxe cruise line, Crystal Cruises, is celebrating culinary prowess in Europe this year, with more than 60 shore excursions that offer an ultra-local taste of the rich culinary regions in which Crystal Serenity and Crystal Symphony are sailing. Hands-on cooking classes, multi-course meals, comestible history lessons, food sourcing, and sampling will be hosted in traditional homes, farms, chateaus, Michelin-starred restaurants and markets. From spring through fall, Crystal offers 65 five- to 15-day European cruise itineraries visiting Spain, Italy, France, Malta, Greece, the UK, Sweden, Norway, Russian, Estonia, Romania, and Morocco.
"Today, there are more and more Crystal 'foodies,' who relish connecting with the culinary nuances and culture of a region in a very authentic, memorable and intimate way," says John Stoll, v.p. of port and land operations.
Ports offering edible excursions include:
• Valetta: Shop at a local open-air market with a Maltese culinary ambassador, then join her at home for a group cooking and dinner party.
• Agadir: Create regional family recipes with Berber chefs, among olive groves.
• Malaga: Glean signature Andalusian dish secrets from the chef/owner of Andalusia's only two-star Michelin restaurant.
• Sicily: Study Sicilian cuisine such as arancine di riso (rice and tomato croquettes) and pennette alla eoliana (pasta with capers, olives, and tomatoes) with mandarin plantation owners.
• Constanta: Cook sarmale cu mamaliguta, a Romanian dish of minced pork, spices, pickled cabbage, and corn flour, at a local restaurant.
• Casablanca: Prepare traditional lamb with plums and honey while sipping orange juice in orange flower water.
• Barcelona: Learn Catalan recipes, from paella to Crema Catalana, in the Gothic Quarter.
• Corfu: See how bread is baked in a traditional garden wood-fire stove, in a private home in one of the island's most traditional old villages.
• Mykonos: Go on a tasting tour of local bakeries, with mouth-watering morsels including amygdalota almond pastry and koulouri sesame buns.
• Sorrento: From a typical farm house to Michelin-starred restaurants, learn from the best local chefs, including the nuances of different mozzarella cheeses, and their application on pizza.
• Bordeaux/Bassens: Sample wild nettle pie, dandelion flower jelly, and multi-course gourmet dinners in a wide range of excursions with topics ranging from the Slow Food movement to chateau visits.
• Bilbao: Indulge in Basque Country cheese, one of the world's finest, in the land of Laxta sheep, or explore three types of pinchos, a typical bread-based appetizer of the region.
• Akureyri: Nibble Icelandic carpaccio, ice cream, and smoke hut lamb during a local farm crawl.
• Tallinn: Assist a master confectioner in creating Estonian chocolates and truffle fillings.
• Honningsvåg: Eat king crab you just pulled fresh from the North Cape waters.
• Stockholm: Follow a modern-day Viking guide through medieval Old Town for Smorgasbord treats.
• Hellesylt/Geiranger: Taste homemade goat caramel from a 300-year-old goat farm on a fjord.
• Bergen: Learn how to prepare local fish like Atlantic salmon and cod at the Norwegian Seafood Center.
Prices for the culinary excursion series start at $62 per person. All-inclusive cruise fares start at $1,895 per person, with additional savings if booked by April 30.
For more information, call (800) 446-6625 or visit crystalcruises.com.


text:
Soil moisture delays corn planting
by WILY/WRXX News Staff • April 9, 2013 • News
We're a week into April, and corn planting has scarcely begun.
There is some anecdotal evidence of corn being planted in Illinois, but there's not yet enough acreage for it to show up in the weekly USDA crop progress report.
According to USDA Crop Statistician Mark Schleusener, the only real field work going on right now (is) primarily anhydrous ammonia applications, also dry fertilizer and herbicides; along with some planting of oats.
At this time last year, 18 percent of the state's corn was already planted.
Topsoil moisture now is 93 percent adequate or surplus, but subsoil moisture is 29 percent short or very short, meaning there isn't much if we have another dry growing season.


text:
March 2 2015 Latest news:
You can use this form to report the content shown below as inappropriate.
If you disagree with a story or a comment please post your own view directly on the piece itself rather than making a complaint.
Please provide full contact details with your complaint, so we can reply or contact you for more details.
I want to complain about this content:
Btw, that Glenn Murray @ QPR would make a good "spare Holt", IMO. Vaughan scored the winner for `Oodersfield last night- vs Murray`s Palace
Mad Brewer
Thursday, January 31, 2013


text:
Helping you to stay abreast of the key challenges facing your industry today, ICIS organises a range of conferences around the world which offer you the chance to hear from key industry leaders, learn about the latest innovations and developments as well as network with your industry colleagues.
Browse the full list of ICIS conferences coming up in the next few months.
There are opportunities to promote your company by sponsoring conferences or booking stand space. Please contact Ken Walford for further details. Telephone: +44 20 8652 3363 or fax: +44 20 8652 8918.
ICIS organises public as well as in-house training. More information here
INSIGHT: China's monetary easing is about damage limitation
"This huge rise in lending has resulted in heavy oversupply in real estate and across many industries, including chemicals."
VIDEO: Supply & demand fundamentals will keep oil low - Hodges
We welcome your feedback. Please feel free to send us your comments on any aspect of this site. Click here to make your comments.
Asian Chemical Connections


text:
First Amendment: Freedom of Speech (1791)
This clause prohibits the government from banning speech because it does not agree with the message. The Founders saw free speech as a natural right. In Federalist No. 10, James Madison pointed to freedom of speech as a vital aspect of a healthy republic. While originally written to apply to actions of the federal government, the Supreme Court incorporated it into state governments through the Fourteenth Amendment in the case Gitlow v. New York (1925)
The English Bill of Rights includes a precursor to the First Amendment's protection of free speech, but while the English Bill of Rights provided for free speech in Parliament, the First Amendment expanded the protection to an individual right of all citizens.
The Alien and Sedition Acts, which outlawed any speech that was critical of government, presented the first challenge to freedom of speech in the early republic. Supreme Court cases centering on freedom of speech include Tinker v. Des Moines (1969), Bethel v. Fraser (1986), and Texas v. Johnson (1989).
Freedom of speech in a self-governing society demands that citizens act with moderation, respect, and responsibility. People like Frederick Douglass, Mary Beth Tinker and Martin Luther King, Jr. have all exercised and fought for the right to freedom of speech.